Valuation: ResMed, Inc.

Market Cap 34.63B 30.85B 28.57B 25.85B 48.71B 3,267B 49.28B 343B 134B 1,718B 130B 127B 5,473B P/E 2027 *
21.2x
P/E 2028 * 19.2x
Enterprise Value 33.67B 30B 27.78B 25.14B 47.36B 3,177B 47.92B 333B 131B 1,670B 126B 124B 5,322B EV / Sales 2027 *
5.8x
EV / Sales 2028 * 5.33x
Free-Float
74.65%
Yield 2027 *
1.09%
Yield 2028 * 1.18%
1 day+0.29%
1 week+4.64%
Current month+11.35%
1 month+10.10%
3 months+25.74%
6 months+11.29%
Current year+2.21%
1 week 235.5
Extreme 235.5
248.6
1 month 218.03
Extreme 218.03
248.6
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
277.67
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
293.81
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 54 28/02/2013
Director of Finance/CFO 41 03/05/2026
Chief Tech/Sci/R&D Officer - 31/01/2024
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 54 24/01/2023
Chairman 84 31/05/1989
Date Insider Type Main position Quantity % Market Cap. Importance
07/10/26 Exercice

Chief Executive Officer

14,973 0.0104%
08/09/26 Exercice

Chief Executive Officer

14,973 0.0104%
08/09/26 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+4.64%-8.21%+70.74% 34.63B
+0.97%+3.09%+24.38%+49.46% 257B
+4.29%+4.08%+5.93%+13.62% 164B
-2.26%+1.88%-7.48%+60.40% 151B
-2.35%+3.51%-55.45%-11.07% 64.51B
+0.65%+4.09%-14.18%-9.33% 52.1B
+0.59%+7.80%+10.60%+59.96% 51.9B
+0.12%+2.26%+16.29%+27.23% 50.95B
+2.74%+2.16%+22.01%+62.73% 50.11B
+3.31%+4.78%+30.99%+80.36% 44.95B
Average +0.70%+3.71%+2.49%+40.41% 92.14B
Weighted average by Cap. +0.82%+3.54%+5.83%+39.69%

Financials

2027 *2028 *
Net sales 5.81B 5.17B 4.79B 4.33B 8.17B 548B 8.26B 57.42B 22.53B 288B 21.78B 21.32B 918B 6.2B 5.52B 5.11B 4.63B 8.72B 585B 8.82B 61.3B 24.05B 307B 23.25B 22.76B 980B
Net income 1.64B 1.46B 1.35B 1.22B 2.31B 155B 2.33B 16.23B 6.37B 81.37B 6.15B 6.03B 259B 1.78B 1.59B 1.47B 1.33B 2.51B 168B 2.54B 17.63B 6.92B 88.38B 6.68B 6.55B 282B
Net Debt -955M -851M -788M -713M -1.34B -90.08B -1.36B -9.44B -3.71B -47.35B -3.58B -3.51B -151B -1.61B -1.44B -1.33B -1.21B -2.27B -152B -2.3B -15.97B -6.27B -80.08B -6.06B -5.93B -255B
Projected Income Statement - Annual - ResMed, Inc.
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
21/10/26 US$246.20 +0.29% 899,292
20/10/26 US$245.50 +2.39% 1,245,217
19/10/26 US$239.77 +0.33% 932,294
16/10/26 US$238.97 -1.35% 2,546,714
15/10/26 US$242.23 +2.95% 1,106,554
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - ResMed, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
246.20USD
Average target price
252.69USD
Spread / Average Target
+2.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed, Inc.